Philips Receives FDA Premarket Approval for its HeartStart FR3 and HeartStart FRx Automated External Defibrillators

Amsterdam, the Netherlands and Cambridge, MA, June 23 (Korea Bizwire) – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) for the company’s HeartStart FR3 [1] and HeartStart FRx [2] automated [...]